Li et al., 2010 - Google Patents
Novel double-antigen sandwich immunoassay for human hepatitis B core antibodyLi et al., 2010
View HTML- Document ID
- 12308933219465321597
- Author
- Li A
- Yuan Q
- Huang Z
- Fan J
- Guo R
- Lou B
- Zheng Q
- Ge S
- Chen Y
- Su Z
- Yeo A
- Chen Y
- Zhang J
- Xia N
- Publication year
- Publication venue
- Clinical and Vaccine Immunology
External Links
Snippet
ABSTRACT A novel diagnostic immunoassay testing procedure for hepatitis B virus core antibody (anti-HBc) using homogeneous purified full-length hepatitis B virus core antigen (HBcAg) capsids obtained from Escherichia coli was compared with Abbott Architect anti …
- 102000004965 antibodies 0 title abstract description 21
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5761—Hepatitis B
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse Transcribing DNA Viruses
- C12N2730/00011—Reverse Transcribing DNA Viruses
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Novel double-antigen sandwich immunoassay for human hepatitis B core antibody | |
Kimura et al. | Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load | |
Kuhns et al. | New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods | |
Hamilton et al. | Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus | |
Ly et al. | Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms | |
EP1801591B1 (en) | Methods for detection or measurement of viruses | |
Kimura et al. | New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA | |
Noborg et al. | Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV monitor test | |
JP3510232B2 (en) | Virus detection or measurement method | |
Takeda et al. | Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay | |
Matsumoto et al. | Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody | |
Weber et al. | Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg | |
Ghosh et al. | Detection of hepatitis B virus infection: a systematic review | |
Mühlbacher et al. | Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants | |
Niederhauser | Reducing the risk of hepatitis B virus transfusion-transmitted infection | |
Seto et al. | Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay | |
Deguchi et al. | Evaluation of the highly sensitive chemiluminescent enzyme immunoassay “Lumipulse HB sAg‐HQ” for hepatitis B virus screening | |
CN108344869B (en) | Hepatitis B surface antigen chemiluminescence immunoassay kit and application thereof | |
Guillou et al. | Evaluation of an enzyme‐linked immunosorbent assay for detection and quantification of hepatitis B virus PreS1 envelope antigen in serum samples: comparison with two commercial assays for monitoring hepatitis B virus DNA | |
Sickinger et al. | Performance characteristics of the high sensitivity Alinity i & ARCHITECT HBsAg Next Qualitative/Confirmatory assays | |
Kuhns et al. | Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors | |
Eble et al. | Differential diagnosis of acute viral hepatitis using rapid, fully automated immunoassays | |
Zaaijer et al. | Early detection of hepatitis B surface antigen and detection of HBsAg mutants: a comparison of five assays | |
Shah et al. | Combination HCV core antigen and antibody assay on a fully automated chemiluminescence analyzer | |
Neurath et al. | Detection of antiviral antibodies with predetermined specificity using synthetic peptide-β-lactamase conjugates: application to antibodies specific for the preS region of the hepatitis B virus envelope proteins |